Literature DB >> 263331

Prolonged hyperprolactinemia in preterm infants.

M Perlman, J Schenker, M Glassman, M Ben-david.   

Abstract

Serum PRL levels were followed serially in full term (FT; 39-41 weeks) and preterm (PT; 30-32 weeks) infants, from birth to 12 and 20 postnatal weeks, respectively. Values were higher in FT infants than in PT infants on day 1 after birth (267 +/- 20 vs. 156 +/- 8 ng/ml) but were similar in both by the age of 2-4 weeks (69 +/- 8 vs. 69 +/- 6 ng/ml). Between the ages of 4-12 weeks, the serum PRL in FT infants fell to near adult levels (24 +/- 2 ng/ml), but this fall was seen much later in PT infants, between 12-20 weeks postnatally (23 +/- 2 ng/ml). When values in FT and PT infants were compared at parallel postmenstrual ages in contradistinction to postnatal ages, a similar course of PRL was discernable in both groups. These data may provide indirect evidence for the establishment and maturation of inhibition of PRL secretion (i.e. PRL-inhibitory factor production) postnatally, between 44-52 weeks postmenstrually.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 263331     DOI: 10.1210/jcem-47-4-894

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  T1 signal intensity and height of the anterior pituitary in neonates: correlation with postnatal time.

Authors:  E Kitamura; Y Miki; M Kawai; H Itoh; S Yura; N Mori; K Sugimura; K Togashi
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-16       Impact factor: 3.825

2.  Plasma prolactin and clinical outcome in preterm infants.

Authors:  A Lucas; B A Baker; T J Cole
Journal:  Arch Dis Child       Date:  1990-09       Impact factor: 3.791

3.  Pituitary gland signal in pre-term infants during the first year of life: an MRI study.

Authors:  Maria I Argyropoulou; Vassilios Xydis; Dimitrios N Kiortsis; Kostantina Pantou; Anastasia Zikou; Stavros C Efremidis; Styliani Andronikou
Journal:  Neuroradiology       Date:  2004-11-17       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.